Načítá se...
Olanzapine has better efficacy compared to risperidone for treatment of negative symptoms in schizophrenia
OBJECTIVE: The safety and efficacy profile of risperidone and olanzapine were compared in a double-blind trial that used doses widely accepted in clinical practice. METHODS: Subjects (n = 71) who met Diagnostic and Statistical Manual of Mental Disorders-IV criteria for schizophrenia were randomly as...
Uloženo v:
| Vydáno v: | Indian J Psychiatry |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Medknow Publications & Media Pvt Ltd
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5100124/ https://ncbi.nlm.nih.gov/pubmed/28066010 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0019-5545.192016 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|